These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1064 related items for PubMed ID: 24527970

  • 21. The detection of HBV DNA with polymerase chain reaction in blood donors with isolated hepatitis B core antibody.
    Tas T, Kaya S, Onal S, Kucukbayrak A.
    Med Glas (Zenica); 2012 Aug; 9(2):227-30. PubMed ID: 22926355
    [Abstract] [Full Text] [Related]

  • 22. [Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg].
    Ren F, Li H, Zhao H.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):7-9. PubMed ID: 10322742
    [Abstract] [Full Text] [Related]

  • 23. Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.
    Kang SY, Kim MH, Lee WI.
    Arch Virol; 2014 Feb; 159(2):227-33. PubMed ID: 23933720
    [Abstract] [Full Text] [Related]

  • 24. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil.
    Silva CM, Costi C, Costa C, Michelon C, Oravec R, Ramos AB, Niel C, Rossetti ML.
    J Infect; 2005 Jul; 51(1):24-9. PubMed ID: 15979486
    [Abstract] [Full Text] [Related]

  • 25. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.
    Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO.
    Virol J; 2016 May 05; 13():76. PubMed ID: 27150469
    [Abstract] [Full Text] [Related]

  • 26. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ.
    Transpl Infect Dis; 2008 Dec 05; 10(6):391-5. PubMed ID: 18665905
    [Abstract] [Full Text] [Related]

  • 27. PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.
    Baghbanian M, Halvani M, Roghani HS, Lotfi MH, Yazdi MF, Vahedian-Ardakani HA.
    Arq Gastroenterol; 2016 Dec 05; 53(3):175-9. PubMed ID: 27438423
    [Abstract] [Full Text] [Related]

  • 28. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors.
    Seo DH, Whang DH, Song EY, Kim HS, Park Q.
    Transfusion; 2011 Aug 05; 51(8):1840-6. PubMed ID: 21332731
    [Abstract] [Full Text] [Related]

  • 29. Are isolated anti-HBc blood donors in high risk group? The detection of HBV DNA in isolated anti-HBc cases with nucleic acid amplification test (NAT) based on transcription-mediated amplification (TMA) and HBV discrimination.
    Altunay H, Kosan E, Birinci I, Aksoy A, Kirali K, Saribas S, Aslan M, Yuksel P, Alan E, Yenen OS, Kocazeybek B.
    Transfus Apher Sci; 2010 Dec 05; 43(3):265-268. PubMed ID: 20934912
    [Abstract] [Full Text] [Related]

  • 30. Hepatitis B viral markers in surface antigen negative blood donors: the need to look beyond antibody negativity.
    Salawu L, Adegoke AO, Aboderin AO, Huraina HA.
    West Afr J Med; 2011 Dec 05; 30(4):292-5. PubMed ID: 22669836
    [Abstract] [Full Text] [Related]

  • 31. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen.
    Hennig H, Puchta I, Luhm J, Schlenke P, Goerg S, Kirchner H.
    Blood; 2002 Oct 01; 100(7):2637-41. PubMed ID: 12239179
    [Abstract] [Full Text] [Related]

  • 32. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
    Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group.
    Transfusion; 2004 Sep 01; 44(9):1332-9. PubMed ID: 15318857
    [Abstract] [Full Text] [Related]

  • 33. The detection of occult HBV infection in patients with HBsAg negative pattern by real-time PCR method.
    Izmirli S, Celik DG, Yuksel P, Saribas S, Aslan M, Ergin S, Bahar H, Sen S, Cakal B, Oner A, Kocazeybek B.
    Transfus Apher Sci; 2012 Dec 01; 47(3):283-7. PubMed ID: 23021041
    [Abstract] [Full Text] [Related]

  • 34. Occult hepatitis B virus infection.
    Allain JP.
    Transfus Clin Biol; 2004 Feb 01; 11(1):18-25. PubMed ID: 14980545
    [Abstract] [Full Text] [Related]

  • 35. Molecular characterization of occult hepatitis B cases in Greek blood donors.
    Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L, Mouzaki A, Andrioti E, Veneti C, Kaperoni A, Zervou E, Politis C, Hatzakis A.
    J Med Virol; 2009 May 01; 81(5):815-25. PubMed ID: 19319945
    [Abstract] [Full Text] [Related]

  • 36. Hepatitis B virus DNA viral load determination in hepatitis B surface antigen-negative Swiss blood donors.
    Stolz M, Tinguely C, Fontana S, Niederhauser C.
    Transfusion; 2014 Nov 01; 54(11):2961-7. PubMed ID: 24805974
    [Abstract] [Full Text] [Related]

  • 37. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
    Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY.
    Transfusion; 2012 Feb 01; 52(2):440-6. PubMed ID: 21810101
    [Abstract] [Full Text] [Related]

  • 38. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L, Strong DM, Tegtmeier G, Stramer S.
    Transfusion; 2008 Nov 01; 48(11):2315-22. PubMed ID: 18647367
    [Abstract] [Full Text] [Related]

  • 39. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.
    Biol Blood Marrow Transplant; 2010 Jun 01; 16(6):809-17. PubMed ID: 20060484
    [Abstract] [Full Text] [Related]

  • 40. Hepatitis B virus markers in anti-HBc only positive individuals.
    Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H.
    J Med Virol; 2001 Jul 01; 64(3):312-9. PubMed ID: 11424120
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 54.